Brief: Braster Gets Approval From National Centre For R&D For Proposed Changes In Oncological Diagnostics Project
Oct 4 (Reuters) - Braster SA w restrukturyzacji BRAR.WA :
* GETS APPROVAL FROM POLAND'S NATIONAL CENTRE FOR RESEARCH
AND
DEVELOPMENT FOR PROPOSED BY COMPANY CHANGES IN PROJECT TIMELINE
* COMPANY PROPOSED TO EXTEND PERIOD OF QUALIFYING COSTS TILL
APRIL
30, 2023 AND INCREASE NUMBER OF TESTED FEMALES TO MINIMUM OF 5
000 PATIENTS
Source text for Eikon: ID:nEM1vN64qa
Further company coverage: BRAR.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Braster SA
See all newsBrief: Braster Prelim. 2022 Net Loss At 4.4 Mln Zlotys
Brief: Braster Resolves To Offer Up To 50,000 M Series Shares At 2.10 Zlotys/SHR
Brief: Braster Expands Collaboration With India-based Genworks Health Private
Brief: Braster W Restrukturyzacji FY Net Loss At 6.8 Mln Zlotys
Brief: Braster Says Accelerated Arrangement Approved In Vote